Hepion Pharmaceuticals Stock Forecast - Polynomial Regression
| HEPA Stock | USD 2.11 0.02 0.94% |
The Polynomial Regression forecasted value of Hepion Pharmaceuticals on the next trading day is expected to be 2.04 with a mean absolute deviation of 0.22 and the sum of the absolute errors of 13.49. Hepion Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Hepion Pharmaceuticals stock prices and determine the direction of Hepion Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Hepion Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Hepion Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Hepion Pharmaceuticals' systematic risk associated with finding meaningful patterns of Hepion Pharmaceuticals fundamentals over time.
Check out Historical Fundamental Analysis of Hepion Pharmaceuticals to cross-verify your projections. Hepion |
Most investors in Hepion Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Hepion Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Hepion Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
Hepion Pharmaceuticals polinomial regression implements a single variable polynomial regression model using the daily prices as the independent variable. The coefficients of the regression for Hepion Pharmaceuticals as well as the accuracy indicators are determined from the period prices. Hepion Pharmaceuticals Polynomial Regression Price Forecast For the 19th of April
Given 90 days horizon, the Polynomial Regression forecasted value of Hepion Pharmaceuticals on the next trading day is expected to be 2.04 with a mean absolute deviation of 0.22, mean absolute percentage error of 0.08, and the sum of the absolute errors of 13.49.Please note that although there have been many attempts to predict Hepion Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Hepion Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Hepion Pharmaceuticals Stock Forecast Pattern
| Backtest Hepion Pharmaceuticals | Hepion Pharmaceuticals Price Prediction | Buy or Sell Advice |
Hepion Pharmaceuticals Forecasted Value
In the context of forecasting Hepion Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Hepion Pharmaceuticals' downside and upside margins for the forecasting period are 0.02 and 9.70, respectively. We have considered Hepion Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Hepion Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Hepion Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.5914 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.2212 |
| MAPE | Mean absolute percentage error | 0.1033 |
| SAE | Sum of the absolute errors | 13.4949 |
Predictive Modules for Hepion Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hepion Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Hepion Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Hepion Pharmaceuticals
For every potential investor in Hepion, whether a beginner or expert, Hepion Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Hepion Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Hepion. Basic forecasting techniques help filter out the noise by identifying Hepion Pharmaceuticals' price trends.Hepion Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hepion Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Hepion Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Hepion Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Hepion Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Hepion Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Hepion Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Hepion Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Hepion Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hepion Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Hepion Pharmaceuticals stock market strength indicators, traders can identify Hepion Pharmaceuticals entry and exit signals to maximize returns.
Hepion Pharmaceuticals Risk Indicators
The analysis of Hepion Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Hepion Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting hepion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.25 | |||
| Standard Deviation | 7.65 | |||
| Variance | 58.58 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hepion Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hepion Pharmaceuticals' short interest history, or implied volatility extrapolated from Hepion Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Hepion Pharmaceuticals to cross-verify your projections. For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Hepion Stock analysis
When running Hepion Pharmaceuticals' price analysis, check to measure Hepion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hepion Pharmaceuticals is operating at the current time. Most of Hepion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hepion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hepion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hepion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |
Is Hepion Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hepion Pharmaceuticals. If investors know Hepion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hepion Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (12.42) | Return On Assets (0.63) | Return On Equity (1.18) |
The market value of Hepion Pharmaceuticals is measured differently than its book value, which is the value of Hepion that is recorded on the company's balance sheet. Investors also form their own opinion of Hepion Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Hepion Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hepion Pharmaceuticals' market value can be influenced by many factors that don't directly affect Hepion Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hepion Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hepion Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hepion Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.